Proposes selective inference for statistically valid testing of anomaly detection methods using generative AI for Alzheimers disease medical imaging. Demonstrates control of false discovery rate and strong power where classical tests can mislead.
Clinical Research
October 30, 2025
Statistical testing on generative AI anomaly detection tools in Alzheimers Disease diagnosis
Selective inference allows valid statistical testing for generative AI-based anomaly detection in Alzheimers.
We believe research isn’t just about data—it’s about delivering actionable insights that fuel progress and change lives
Alex Tran
Founder & Chief Scientist
